Source:http://linkedlifedata.com/resource/pubmed/id/12072014
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2002-6-19
|
pubmed:abstractText |
Elevated IgE responses and eosinophilia observed in patients with atopic dermatitis (AD) may reflect increased responses of type 2 T-helper (Th2) cytokines with a concomitant decrease in interferon-gamma (IFN-gamma) production. However, the cross-regulation of Th1/Th2 derivation and function in AD patients are incompletely characterized. Therefore, we investigated serum levels of several cytokines [interleukin (IL)-18, IL-12, IL-10, IL-2 and IFN-gamma] in patients with AD to assess their possible relationships to the severity of disease. Serum IL-18 levels in AD patients were significantly higher than those in healthy controls [207 pg/mL; 95% confidence interval (CI), 172-242 pg/mL vs. 144 pg/mL; 95% CI, 116-178 pg/mL; P = 0.026]. Those IL-18 levels significantly correlated with eosinophil counts and serum soluble IL-2 receptor (sIL-2R) levels, and showed a tendency to correlate with clinical severity scores and serum IgE levels. IL-2 levels showed a significantly inverse correlation with serum IgE levels, and IL-12 levels clearly correlated with IL-10 levels. These results suggest the value of serum IL-18 levels as a parameter of AD activity and may support a possible role for IL-18 in the pathogenesis of AD. The inverse correlation between IgE levels and IL-2 levels suggests that IgE production may be inhibited by IL-2 in patients with AD. Furthermore, the correlation of IL-12 levels with IL-10 levels may support the previous reports that show the induction of IL-10 production by human natural killer cells and/or T cells stimulated with IL-12 in vitro.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cytokines,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin E,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-10,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-12,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-18,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-2,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interleukin-2
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0307-6938
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
225-9
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:12072014-Adolescent,
pubmed-meshheading:12072014-Adult,
pubmed-meshheading:12072014-Cytokines,
pubmed-meshheading:12072014-Dermatitis, Atopic,
pubmed-meshheading:12072014-Female,
pubmed-meshheading:12072014-Humans,
pubmed-meshheading:12072014-Immunoglobulin E,
pubmed-meshheading:12072014-Interleukin-10,
pubmed-meshheading:12072014-Interleukin-12,
pubmed-meshheading:12072014-Interleukin-18,
pubmed-meshheading:12072014-Interleukin-2,
pubmed-meshheading:12072014-Male,
pubmed-meshheading:12072014-Receptors, Interleukin-2,
pubmed-meshheading:12072014-Severity of Illness Index
|
pubmed:year |
2002
|
pubmed:articleTitle |
Serum cytokine levels in atopic dermatitis.
|
pubmed:affiliation |
Department of Dermatology, Saitama Medical Center, Saitama Medical School, Japan. yyusuke@cc.mbn.or.jp
|
pubmed:publicationType |
Journal Article
|